Aquestive Therapeutics, Inc. 03843E104 US03843E1047 06/11/2025 RESOLVED, that the compensation paid to Aquestive Therapeutics Inc.’s named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the compensation tables and any related material disclosed in this proxy statement, is hereby approved. SECTION 14A SAY-ON-PAY VOTES 9810958 0 FOR 9810958 FOR